Scientific work

Doç. Dr. Tamer Aksoy

53 publications. The source of the information is stated next to each publication.

Back to profile

  1. Performance of [89Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial

    European Urology, 2026

    DOI 10.1016/j.eururo.2026.03.003 PMID 42025513 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  2. Prognostic and Predictive Values of F-18 FDG PET/CT Volumetric Parameters in Small Cell Lung Cancer

    Molecular Oncologic Imaging, 2025

    DOI 10.71286/moi.1582606 3 citations (OpenAlex) Open-access full textSource: ORCID

  3. The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005394 PMID 39086038 18 citations (OpenAlex) Source: OpenAlex

  4. [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

    The Lancet Oncology, 2024

    DOI 10.1016/s1470-2045(24)00402-9 PMID 39270701 175 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. [89Zr]Zr-DFO-girentuximab pour l’imagerie par TEP/TDM des cancers du rein à cellules claires – Résultats de l’étude de phase 3 ZIRCON

    Médecine Nucléaire, 2024

    DOI 10.1016/j.mednuc.2024.01.008 Source: OpenAlex

  6. 68Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity A Head-to-Head Comparative Study

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004751 PMID 37351868 32 citations (Europe PMC) Source: ORCID

  7. 68Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004782 PMID 37565817 3 citations (OpenAlex) Source: OpenAlex

  8. 68Ga-PSMA PET/CT Found Lower Respiratory Tract Inflammation Due to Inhaler Use

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000005015 PMID 38170919 Source: OpenAlex

  9. Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

    Journal of Clinical Oncology, 2023

    DOI 10.1200/jco.2023.41.6_suppl.lba602 38 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study.

    Journal of Clinical Oncology, 2023

    DOI 10.1200/jco.2023.41.16_suppl.4554 10 citations (OpenAlex) Open-access full textSource: OpenAlex

  11. LBA03-01 89 Zr-DFO-GIRENTUXIMAB FOR PET/CT IMAGING OF INDETERMINATE RENAL MASSES–RESULTS FROM PHASE 3 ZIRCON STUDY

    The Journal of Urology, 2023

    DOI 10.1097/ju.0000000000003426.01 Source: OpenAlex

  12. P216 Tracking bone health in paediatric patients with spinal muscular atrophy (SMA)

    Neuromuscular Disorders, 2023

    DOI 10.1016/j.nmd.2023.07.098 Source: OpenAlex

  13. TEP/TDM au 89ZR-DFO-Girentuximab pour l’imagerie des carcinomes rénaux à cellules claires–résultats de l’étude de phase III ZIRCON

    Progrès en Urologie - FMC, 2023

    DOI 10.1016/j.fpurol.2023.07.090 Source: OpenAlex

  14. Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022

    DOI 10.4274/tjh.galenos.2020.2020.0693 PMID 33374099 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  15. Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2021.71501 PMID 35770951 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  16. Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2021.28190 PMID 35114758 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  17. Sarkomlar ve Cilt Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1097 Open-access full textSource: OpenAlex

  18. 68Ga-PSMA uptake in a radioiodine-refractory metastatic differentiated thyroid cancer patient,Captación de 68Ga-PSMA en un paciente con cáncer de tiroides diferenciado metastásico resistente al yodo radiactivo

    Revista Espanola de Medicina Nuclear e Imagen Molecular, 2022

    DOI 10.1016/j.remn.2021.06.002 Source: ORCID

  19. Systemic Sarcoidosis Induced by Chemotherapy, Mimicking Metastatic Testicular Carcinoma with 18F-FDG PET/CT

    Molecular imaging and radionuclide therapy, 2021

    DOI 10.4274/mirt.galenos.2020.51422 PMID 34082518 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  20. 68Ga PSMA Uptake at Roux-en-Y Eso-jejunostomy Junction Mimicking the Recurrence of Gastric Carcinoma in PET/CT

    Molecular imaging and radionuclide therapy, 2021

    DOI 10.4274/mirt.galenos.2020.86729 PMID 33586413 Open-access full textSource: Europe PMC

  21. 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma

    Molecular imaging and radionuclide therapy, 2021

    DOI 10.4274/mirt.galenos.2021.92053 PMID 34082503 21 citations (Europe PMC) Open-access full textSource: Europe PMC

  22. PET/CT in The Evaluation of Treatment Response in Gynecological Cancers

    Nuclear Medicine Seminars, 2021

    DOI 10.4274/nts.galenos.2021.0016 Open-access full textSource: ORCID

  23. 68Ga-PSMA uptake in a radioiodine-refractory metastatic differentiated thyroid cancer patient

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2021

    DOI 10.1016/j.remnie.2021.07.002 PMID 34340959 1 citation (OpenAlex) Source: OpenAlex

  24. The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers

    Molecular imaging and radionuclide therapy, 2020

    DOI 10.4274/mirt.galenos.2019.33866 PMID 32079384 16 citations (Europe PMC) Open-access full textSource: Europe PMC

  25. Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas

    Molecular imaging and radionuclide therapy, 2020

    DOI 10.4274/mirt.galenos.2020.75537 PMID 32079385 11 citations (Europe PMC) Open-access full textSource: Europe PMC

  26. Renal Cortical Scintigraphy Procedure Guideline

    Nuclear Medicine Seminars, 2020

    DOI 10.4274/nts.galenos.2020.0018 Open-access full textSource: OpenAlex

  27. Imaging Guideline in Pediatric Neuroblastoma Patients

    Nuclear Medicine Seminars, 2020

    DOI 10.4274/nts.galenos.2020.0017 Open-access full textSource: OpenAlex

  28. Elastofibroma Dorside Ga-68 DOATATE PET-BT İle Gösterilen Somatostatin Reseptör Ekspresyonu

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2020

    DOI 10.31067/0.2020.327 Open-access full textSource: OpenAlex

  29. Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT

    Revista da Associação Médica Brasileira, 2020

    DOI 10.1590/1806-9282.66.5.673 PMID 32638964 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  30. 18F-FDG PET/CT in Xanthoma Disseminatum

    Clinical Nuclear Medicine, 2020

    DOI 10.1097/rlu.0000000000003181 PMID 32657869 1 citation (OpenAlex) Source: OpenAlex

  31. Detailed analyses about predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in invasive lobular breast cancer

    Biomedical and Biotechnology Research Journal (BBRJ), 2020

    DOI 10.4103/bbrj.bbrj_72_20 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  32. The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with breast cancer

    Nuclear Medicine Communications, 2019

    DOI 10.1097/mnm.0000000000001133 PMID 31895261 8 citations (OpenAlex) Source: OpenAlex

  33. Elastofibroma Dorsi: Positron Emission Tomography/Computed Tomography Perspective

    Istanbul Medical Journal, 2019

    DOI 10.4274/imj.galenos.2019.55563 Open-access full textSource: OpenAlex

  34. Colonic Malignant Melanoma: 18F-FDG PET/CT Findings

    Molecular Imaging and Radionuclide Therapy, 2018

    DOI 10.4274/mirt.65807 PMID 30317855 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  35. Is Dual-Time-Point Imaging Necessary for Discrimination of Adrenal Benign Lesions Versus Malignant Masses: A Study Comparing Standard Methods with Dual-Time-Point FDG PET-CT Imaging

    Chemotherapy Open access, 2018

    DOI 10.4172/2167-7700.1000258 Source: OpenAlex

  36. Comparison of wire-guided localization and radio-guided occult lesionlocalization in preoperative localization of nonpalpable breast lesions

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016

    DOI 10.3906/sag-1507-162 PMID 28081335 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. TSNM, Procedure Guideline for Dynamic Renal Scintigraphy in Children 2.0

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.003 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  38. TSNM, Procedure Guidelines for Pediatric Bone Imaging with Tc-99m Labeled RAdiopharmaceuticals and F-18 Fluoride 2.0

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.005 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  39. TSNM, Procedure Guideline for Radioiodinated MIBG Scintigraphy in Children 2.0

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.010 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  40. TSNM, Procedure Guideline for Radionuclide Cystography in Children

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.004 Open-access full textSource: OpenAlex

  41. TSNM, Procedure Guidelines for Oncologic F-18 FDG PET-CT imaging in Children

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.013 Open-access full textSource: OpenAlex

  42. TSNM, Procedure Guideline of Renal Cortical Scintigraphy in Children 2.0

    Nuclear Medicine Seminars, 2015

    DOI 10.4274/nts.2015.002 Open-access full textSource: OpenAlex

  43. TNTD, Çocuklarda Tc-99m ile İşaretli Radyofarmasötikler ve Florit ile Kemik Görüntüleme Kılavuzu 2.0

    2015

    Source: OpenAlex

  44. Evaluating the Role of Routine Prone Acquisition on Visual Evaluation of SPECT Images

    Journal of Nuclear Medicine Technology, 2015

    DOI 10.2967/jnmt.115.165936 PMID 26584617 8 citations (OpenAlex) Open-access full textSource: OpenAlex

  45. PET–BT incelenmesi yapılan melanom hastalarının retrospektif analizi

    TURKDERM, 2013

    DOI 10.4274/turkderm.30306 Open-access full textSource: OpenAlex

  46. Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren’s syndrome

    Clinical Rheumatology, 2012

    DOI 10.1007/s10067-012-2024-2 PMID 22733368 20 citations (OpenAlex) Source: OpenAlex

  47. Obscure and occult gastrointestinal bleeding: role of radionuclide imaging

    Abdominal Imaging, 2012

    DOI 10.1007/s00261-012-9841-2 PMID 22302119 7 citations (OpenAlex) Source: OpenAlex

  48. Gastroesophageal reflux scintigraphy: interpretation methods and inter-reader agreement

    World Journal of Pediatrics, 2011

    DOI 10.1007/s12519-011-0322-4 PMID 21822991 14 citations (OpenAlex) Source: OpenAlex

  49. Is the predicted postoperative FEV1 estimated by planar lung perfusion scintigraphy accurate in patients undergoing pulmonary resection? Comparison of two processing methods

    Annals of Nuclear Medicine, 2010

    DOI 10.1007/s12149-010-0378-6 PMID 20379857 5 citations (OpenAlex) Source: OpenAlex

  50. The role of metamizol induction for the detection of perfusion reversibility on thallium-201 myocardial perfusion scintigraphy

    Nuclear Medicine Communications, 2010

    DOI 10.1097/mnm.0b013e3283413041 PMID 21063233 Source: OpenAlex